Affirm Holdings, Inc. Share Price Target ‘$36.72’, now 11.2% Upside Potential

DirectorsTalk Interviews

Affirm Holdings, Inc. with ticker code (AFRM) have now 15 market analysts covering the stock. The analyst consensus now points to a rating of ‘hold’. The target price High/Low ranges between $65.00 and $20.00 calculating the mean target share price we have $36.72. (at the time of writing). Now with the previous closing price of $33.03 this now indicates there is a potential upside of 11.2%. Also worth taking note is the 50 day moving average now sits at $33.77 while the 200 day moving average is $31.11. The company has a market capitalization of 9.98B. The stock price is currently at: $32.28 USD

The potential market cap would be $11,093,324,747 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of -, revenue per share of $6.90 and a -5.8% return on assets.

Affirm Holdings, Inc. provides a platform for digital and mobile-first commerce. The Company’s platform comprises three elements: point-of-sale payment solutions for consumers, merchant commerce solutions, and a consumer-focused app. Its point-of-sale solutions allow consumers to pay for purchases in fixed amounts without deferred interest, late fees, or penalties. Its merchant commerce solutions offer commerce enablement, demand generation, and customer acquisition tools. Its consumer-focused app provides Affirm products, which consumers can use to manage payments, open a high-yield savings account, and access a personalized marketplace. The Company’s platform provides consumer and merchant features. Its consumer features include checkout, consumer borrowing, virtual card, affirm app and marketplace and Affirm debit+ card. Its merchant features include affirm at Checkout, merchant dashboard, analytics, client success support, affirm app, and returns management, among others.

Share on:
Find more news, interviews, share price & company profile here for:

    Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months

    Fidelity Emerging Markets achieved a NAV total return of 34.3% and a share price return of 40.3% for the year to 30 September 2025, outperforming the MSCI EM Index.

    Nuformix receives FDA clarification request and reports 408% oversubscription in Open Offer

    Nuformix has received an FDA request for clarification on its Orphan Drug Designation application for tranilast under the NXP002 programme. The company also reported its Open Offer was oversubscribed by 408%, raising around £228,000 before expenses.

    Firering Strategic Minerals receives US$1m Ricca settlement to boost Limeco stake

    Firering Strategic Minerals has agreed a US$1m cash settlement from Skylark Minerals to resolve all outstanding debts owed by Ricca Resources.

    Ruffer Investment Company reports October gains as equities and UK bonds lift performance

    Ruffer Investment Company continued to make positive progress in October, supported by its equity and long-dated UK bond positions.

    Norcros plc to host Interim Results investor webinar on 1st December

    Norcros will hold an Investor Presentation Webinar covering its Interim Results for the 27 weeks to 5 October 2025.

    Time Finance lending portfolio reaches record £230m ahead of H1 trading update

    Time Finance has reported a record lending portfolio of £230m as of 31 October 2025, up 6% since May and 12% year-on-year.

      Search

      Search